Background
Since the beginning of the COVID-19 pandemic, empirical antibiotics prescription has increased globally in patients with COVID-19 for suspected or confirmed bacterial infection. Hence, concerns have been raised about potential rise in antibiotic resistance that will create further challenges for antimicrobial stewardship.